BCYC: Bicycle Therapeutics plc insider trading, 5% holders and institutional ownership

From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.

Insider trading

0 open-market buys totaling - and 14 sales totaling $64K in the last 180 days.

Insider sales

Trade dateInsiderRoleValue10b5-1 plan
2026-10-05Perry Jennifer ScottOfficer$107yes
2026-10-05Perry Jennifer ScottOfficer$1Kyes
2026-10-05Perry Jennifer ScottOfficer$285yes
2026-10-05Perry Jennifer ScottOfficer$1Kyes
2026-10-05Hannay Michael Charles FergusonOfficer$864
2026-10-05Thompson Travis AlvinCFO$282
2026-10-05Lee KevinCEO$6K
2026-10-05Skynner MichaelOfficer$2K
2026-10-02Perry Jennifer ScottOfficer$4Kyes
2026-10-02Swanton Robert CharlesDirector$12K
2026-10-02Hannay Michael Charles FergusonOfficer$5K
2026-10-02Thompson Travis AlvinCFO$3K
2026-10-02Lee KevinCEO$21K
2026-10-02Skynner MichaelOfficer$7K

Activist and 5% holders

FiledWhatHolderStakeChangeFiling
2026-08-1413G amendmentArmistice Capital, LLC6.72%SEC

Institutional ownership (Q2 2026)

103 institutions reported holding $146.14M of Bicycle Therapeutics plc on Form 13F (98 the quarter before). 18 opened a new position and 13 sold out. Shares held by institutions: same.

Largest holdersSharesValue
BAKER BROS. ADVISORS LP10,885,357$46.15M
FCPM III SERVICES B.V.3,468,430$14.71M
ARMISTICE CAPITAL, LLC3,398,000$14.41M
Long Focus Capital Management, LLC3,310,687$14.04M
RENAISSANCE TECHNOLOGIES LLC1,533,400$6.50M
GSK plc1,529,561$6.49M
MARSHALL WACE, LLP797,940$3.38M
Qube Research & Technologies Ltd775,567$3.29M
MORGAN STANLEY667,269$2.83M
SCHRODER INVESTMENT MANAGEMENT GROUP615,833$2.56M

Get new insider and activist filings the morning after: daily alerts. Not investment advice.